Provided by Tiger Trade Technology Pte. Ltd.

Tyra Biosciences, Inc.

36.29
-1.7400-4.58%
Post-market: 36.290.00000.00%16:38 EDT
Volume:671.95K
Turnover:24.65M
Market Cap:1.95B
PE:-18.03
High:38.39
Open:37.72
Low:36.18
Close:38.03
52wk High:39.15
52wk Low:6.42
Shares:53.87M
Float Shares:17.22M
Volume Ratio:0.65
T/O Rate:3.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0125
EPS(LYR):-2.0125
ROE:-39.83%
ROA:-25.68%
PB:7.54
PE(LYR):-18.03

Loading ...

Press Release: Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Dow Jones
·
Mar 03

Tyra Biosciences Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Feb 24

Cantor Fitzgerald Initiates Tyra Bioscience at Overweight

MT Newswires Live
·
Feb 24

Raymond James Reaffirms Their Buy Rating on Tyra Bioscience (TYRA)

TIPRANKS
·
Feb 24

Tyra Biosciences to Present Two Posters at 2026 ASCO GU Cancers Symposium

Reuters
·
Feb 24

Tyra Biosciences Announces Phase 2 SURF302 Study of Dabogratinib in FGFR3-Altered Non-Muscle Invasive Bladder Cancer

Reuters
·
Feb 24

Tyra Biosciences to Present at Oppenheimer Life Sciences Healthcare Conference

Reuters
·
Feb 20

Tyra Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 17

Tyra Biosciences Inc : H.c. Wainwright Raises Target Price to $45 From $30

THOMSON REUTERS
·
Feb 17

Tyra Biosciences price target raised to $45 from $30 at H.C. Wainwright

TIPRANKS
·
Feb 17

U.S. RESEARCH ROUNDUP-Brixmor Property, Mohawk Industries, UDR

Reuters
·
Feb 17

Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Tyra Bioscience (TYRA)

TIPRANKS
·
Feb 15

Tyra Biosciences Chief Discovery Officer Daniel Bensen Reports Disposal of Common Shares

Reuters
·
Feb 14

Tyra Biosciences Advances TYRA-300 Bladder Cancer Trial: What Investors Should Watch

TIPRANKS
·
Feb 14

Tyra Biosciences Is Maintained at Outperform by Wedbush

Dow Jones
·
Feb 13

Wedbush Sticks to Its Buy Rating for Tyra Bioscience (TYRA)

TIPRANKS
·
Feb 13

Wedbush Raises Price Target on Tyra Bioscience to $53 From $37, Keeps Outperform Rating

MT Newswires Live
·
Feb 13

Tyra Biosciences participates in a coferejce call with William Blair

TIPRANKS
·
Feb 12

William Blair Initiates Tyra Bioscience at Outperform

MT Newswires Live
·
Feb 10

Analysts Offer Insights on Healthcare Companies: Tyra Bioscience (TYRA) and Novo Nordisk (NVO)

TIPRANKS
·
Feb 10